Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 01, 2018

SELL
$71.28 - $78.92 $13.7 Million - $15.2 Million
-192,286 Closed
0 $0
Q2 2018

Aug 01, 2018

BUY
$64.88 - $75.68 $8.26 Million - $9.63 Million
127,286 Added 195.82%
192,286 $13.6 Million
Q1 2018

May 04, 2018

BUY
$72.84 - $88.8 $4.73 Million - $5.77 Million
65,000 New
65,000 $4.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sea Town Holdings Pte. Ltd. Portfolio

Follow Sea Town Holdings Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Town Holdings Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sea Town Holdings Pte. Ltd. with notifications on news.